Every material Form 8-K Central Garden & Pet filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Central Garden & Pet reported fiscal 2025 net sales of $3.1 billion, down from $3.2 billion, while GAAP diluted EPS rose to $2.55 from $1.62 and non-GAAP diluted EPS rose to $2.73 from $2.13. The company expects fiscal 2026 non-GAAP EPS of $2.70 or better, which is slightly below the fiscal 2025 non-GAAP result, and the results are preliminary until its Form 10-K is filed.
Fiscal 2025 net sales were $3.1 billion versus $3.2 billion, a decrease of 2%.
Fiscal 2025 GAAP diluted EPS was $2.55 versus $1.62; non-GAAP diluted EPS was $2.73 versus $2.13.
Fourth-quarter net sales were $678 million versus $669 million, and the net loss narrowed to $10 million from $34 million.
Fiscal 2026 outlook calls for non-GAAP EPS of $2.70 or better and capital spending of $50 million to $60 million.
Central Garden & Pet signed a Fourth Amended and Restated Credit Agreement on November 7, 2025, providing a $600 million senior secured asset-based revolving credit facility that matures November 7, 2030. The company did not draw any commitments at closing, and the facility can be increased by up to an additional $400 million if lenders agree, which gives the company borrowing capacity for general corporate purposes.
Facility size: $600 million revolver, with up to $400 million more available through an uncommitted accordion feature
Maturity: November 7, 2030; replaces the Third Amended and Restated Credit Agreement dated December 16, 2021
No borrowings drawn at closing; pricing at closing was SOFR plus 1.00% on SOFR-based loans
Secured by substantially all assets of the company and guarantor subsidiaries, with a minimum fixed charge coverage ratio of 1.00:1.00 when triggered
Central Garden & Pet reported fiscal third-quarter 2025 results for the period ended June 28, 2025. Net sales fell 4% to $961 million, while GAAP diluted earnings per share rose to $1.52 from $1.19, helped by gross margin expansion from its Cost and Simplicity program. The company reaffirmed its fiscal 2025 non-GAAP EPS outlook of approximately $2.60.
Net sales were $961 million, down 4%; Pet segment sales fell 3% and Garden segment sales fell 4%.
GAAP diluted EPS was $1.52 vs. $1.19 a year earlier; non-GAAP diluted EPS was $1.56 vs. $1.32.
Gross margin expanded 280 basis points to 34.6%; the company repurchased 1.7 million shares for $55 million in the quarter.
Fiscal 2025 non-GAAP EPS outlook of approximately $2.60 was reaffirmed, not changed.
Central Garden & Pet said on July 11, 2025 that it raised its fiscal 2025 non-GAAP earnings per share outlook to approximately $2.60, citing margin expansion from its Cost and Simplicity initiatives and a favorable product mix. The filing does not state the prior outlook, so the size of the increase cannot be determined from this document. The company also cautioned that its fourth quarter is seasonally small and that consumer demand remains uncertain.
Fiscal 2025 non-GAAP EPS outlook raised to approximately $2.60 for the fiscal year ending September 28, 2025
Company expects fiscal 2025 capital expenditures of approximately $60 million
Outlook excludes the potential impact of further tariff changes and any acquisitions, divestitures, or restructuring
Additional details to be provided on the fiscal 2025 third-quarter earnings call on August 6, 2025
Central Garden & Pet reported fiscal second-quarter 2025 results for the period ended March 29, 2025. Net sales fell 7% to $834 million, while GAAP diluted EPS rose to $0.98 from $0.93, and the company reaffirmed its fiscal 2025 non-GAAP EPS outlook of $2.20 or better, which matters to shareholders because sales declined even as per-share earnings grew.
Net sales were $834 million, down 7%; Pet segment sales fell 6% to $454 million and Garden segment sales fell 10% to $380 million.
GAAP diluted EPS was $0.98 versus $0.93 a year earlier; non-GAAP diluted EPS was $1.04 versus $0.99.
Fiscal 2025 non-GAAP EPS outlook was reaffirmed at $2.20 or better.
Central repurchased $41 million of stock during the quarter and $39 million more through April 30, 2025, with $63 million remaining available.
At its February 12, 2025 annual meeting, shareholders elected all ten director nominees and ratified Deloitte & Touche LLP as the independent auditor for fiscal 2025. The filing also discloses fiscal 2024 cash bonuses approved February 11, 2025, which were left out of the proxy statement because the amounts had not yet been set.
Christopher T. Metz received 13,980,186 votes for and 5,321,592 withheld, the weakest support among the ten nominees.
Deloitte & Touche LLP was ratified with 19,566,205 votes for and 268,191 against.
Non-equity incentive pay for fiscal 2024 includes $920,000 for Mary Beth Springer and $341,000 for John Hanson; the Board withdrew Proposal Three on an officer exculpation amendment.
Central Garden & Pet reported first quarter fiscal 2025 results for the period ended December 28, 2024, with net sales up 3% to $656 million and EPS of $0.21 versus $0.01 a year earlier. The company kept its fiscal 2025 non-GAAP EPS outlook of $2.20 or better, but management said the quarter benefited from the timing of shipments and promotions.
Net sales rose 3% to $656 million from $635 million a year ago; net income was $14 million versus $0.4 million.
Gross margin improved 160 basis points to 29.8%; operating income rose to $28 million from $8 million.
Cash used by operations was $69 million; the company repurchased $52 million of stock, with $131 million remaining under its authorization.
Fiscal 2025 non-GAAP EPS outlook of $2.20 or better was maintained, excluding acquisitions, divestitures or restructuring.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Central Garden & Pet filing is on SEC EDGAR ↗. 8-K briefs of other companies →